B.-M. Landgren

1.3k total citations
37 papers, 1.1k citations indexed

About

B.-M. Landgren is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, B.-M. Landgren has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Reproductive Medicine, 14 papers in Public Health, Environmental and Occupational Health and 9 papers in Immunology. Recurrent topics in B.-M. Landgren's work include Ovarian function and disorders (17 papers), Reproductive System and Pregnancy (9 papers) and Endometriosis Research and Treatment (8 papers). B.-M. Landgren is often cited by papers focused on Ovarian function and disorders (17 papers), Reproductive System and Pregnancy (9 papers) and Endometriosis Research and Treatment (8 papers). B.-M. Landgren collaborates with scholars based in Sweden, United Kingdom and Switzerland. B.-M. Landgren's co-authors include E. Diczfalusy, Anna‐Lena Undén, A.-R. Aedo, P. Eneroth, Aila Collins, Z. Čekan, E. Johannisson, Kerstin Hagenfeldt, S.Z. Cekan and G. Csemiczky and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, Human Reproduction and Fertility and Sterility.

In The Last Decade

B.-M. Landgren

36 papers receiving 983 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.-M. Landgren Sweden 18 426 408 203 153 137 37 1.1k
Mary G. Metcalf New Zealand 18 481 1.1× 477 1.2× 386 1.9× 212 1.4× 61 0.4× 59 1.2k
Ulrich A. Knuth Germany 22 512 1.2× 981 2.4× 403 2.0× 185 1.2× 49 0.4× 49 1.4k
H H McGarrigle United Kingdom 24 525 1.2× 481 1.2× 234 1.2× 153 1.0× 74 0.5× 45 1.6k
Jean‐Pierre Louvet France 14 390 0.9× 367 0.9× 184 0.9× 166 1.1× 69 0.5× 21 987
Peter Burton Australia 13 222 0.5× 312 0.8× 175 0.9× 61 0.4× 78 0.6× 31 840
Carlene W. Elsner United States 15 917 2.2× 926 2.3× 154 0.8× 123 0.8× 137 1.0× 39 1.6k
Kerstin Hagenfeldt Sweden 26 550 1.3× 452 1.1× 888 4.4× 390 2.5× 315 2.3× 82 2.3k
Richard N. Andersen United States 26 675 1.6× 803 2.0× 799 3.9× 278 1.8× 92 0.7× 56 2.2k
M. Yusoff Dawood United States 12 369 0.9× 326 0.8× 70 0.3× 46 0.3× 100 0.7× 15 725
G. Thorbert Sweden 16 321 0.8× 212 0.5× 43 0.2× 60 0.4× 98 0.7× 28 867

Countries citing papers authored by B.-M. Landgren

Since Specialization
Citations

This map shows the geographic impact of B.-M. Landgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.-M. Landgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.-M. Landgren more than expected).

Fields of papers citing papers by B.-M. Landgren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.-M. Landgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.-M. Landgren. The network helps show where B.-M. Landgren may publish in the future.

Co-authorship network of co-authors of B.-M. Landgren

This figure shows the co-authorship network connecting the top 25 collaborators of B.-M. Landgren. A scholar is included among the top collaborators of B.-M. Landgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.-M. Landgren. B.-M. Landgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stavreus‐Evers, Anneli, et al.. (2006). P-387. Fertility and Sterility. 86(3). S279–S279. 1 indexed citations
2.
Johannesson, Magnus, B.-M. Landgren, G. Csemiczky, Lena Hjelte, & C. Gottlieb. (1998). Female patients with cystic fibrosis suffer from reproductive endocrinological disorders despite good clinical status. Human Reproduction. 13(8). 2092–2097. 46 indexed citations
4.
Landgren, B.-M., Baldvin Jónsson, & S.Z. Cekan. (1995). The effect of small doses of progesterone released from two types of vaginal rings on ovarian activity and bleeding patterns during the first postpartum year. Contraception. 51(4). 255–260. 7 indexed citations
5.
Csemiczky, G., H. Wramsby, & B.-M. Landgren. (1995). Ovarian function in relation to the outcome of in vitro fertilization (IVF) treatment in regularly menstruating women with tubal infertility. Journal of Assisted Reproduction and Genetics. 12(10). 683–688. 12 indexed citations
6.
Landgren, B.-M., et al.. (1994). Pharmacokinetic and pharmacodynamic effects of vaginal rings releasing levonorgestrel at a rate of 27 μg/24 hours: A pilot study. Contraception. 49(2). 139–150. 12 indexed citations
7.
Landgren, B.-M., et al.. (1992). Is the contraceptive effect of 300 μg of norethisterone mainly peripheral or central?. Contraception. 45(1). 57–66. 15 indexed citations
8.
Blombäck, Margareta, P. Eneroth, B.-M. Landgren, Maria Lagerström, & Olin D. Anderson. (1992). On the Intraindividual and Gender Variability of Haemostatic Components. Thrombosis and Haemostasis. 67(1). 70–75. 46 indexed citations
9.
Landgren, B.-M., Peter E. Hall, & S.Z. Cekan. (1992). Progesterone-releasing vaginal rings for use in postpartum contraception. II. Pharmacokinetic profiles in women. Contraception. 45(4). 343–349. 6 indexed citations
10.
Landgren, B.-M., et al.. (1991). Peritoneal fluid volume and levels of steroid hormones and gonadotrophins in peritoneal fluid of normal and norethisterone-treated women. Human Reproduction. 6(9). 1233–1237. 7 indexed citations
12.
Aedo, A.-R., B.-M. Landgren, & E. Diczfalusy. (1990). Pharmacokinetics and biotransformation of orally administered oestrone sulphate and oestradiol valerate in post-menopausal women. Maturitas. 12(4). 333–343. 25 indexed citations
13.
Landgren, B.-M., et al.. (1990). Pituitary, ovarian and endometrial effects of 300 μg norethisterone and 30 μg levonorgestrel administered on cycle days 7 to 10. Contraception. 41(6). 569–581. 4 indexed citations
14.
Jonsson, Bo H., B.-M. Landgren, & P. Eneroth. (1989). Repeated mid-cycle tests of in-vitro sperm penetration (Kremer tests) in healthy women during three menstrual cycles. Human Reproduction. 4(6). 670–673. 6 indexed citations
15.
Aedo, A.-R., Maria Le Donne, B.-M. Landgren, & E. Diczfalusy. (1989). Effect of orally administered oestrogens on gonadotrophin levels in post-menopausal women. Maturitas. 11(2). 147–157. 6 indexed citations
16.
17.
Collins, Aila, P. Eneroth, & B.-M. Landgren. (1985). Psychoneuroendocrine stress responses and mood as related to the menstrual cycle.. Psychosomatic Medicine. 47(6). 512–527. 112 indexed citations
18.
19.
Landgren, B.-M., et al.. (1984). Hormonal consequences oe missing the pill during the first two days of three consecutive artificial cycles. Contraception. 29(5). 437–446. 24 indexed citations
20.
Landgren, B.-M., S. Campo, S.Z. Cekan, & E. Diczfalusy. (1977). STUDIES ON THE PATTERN OF CIRCULATING STEROIDS IN THE NORMAL MENSTRUAL CYCLE. European Journal of Endocrinology. 86(3). 608–620. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026